Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging

Abstract Background Programmed cell death 1 (PD-1) belongs to immune checkpoint proteins ensuring negative regulation of the immune response. In non-small cell lung cancer (NSCLC), the sensitivity to treatment with anti-PD-1 therapeutics, and its efficacy, mostly correlated with the increase of tumo...

Descrición completa

Detalles Bibliográficos

Principais autores:	Joanna Maria Mierzwicka, Hana Petroková, Leona Rašková Kafková, Petr Kosztyu, Jiří Černý, Milan Kuchař, Miloš Petřík, Kateřina Bendová, Kristýna Krasulová, Yaroslava Groza, Lucie Vaňková, Shiv Bharadwaj, Natalya Panova, Michal Křupka, Jozef Škarda, Milan Raška, Petr Malý
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-05-01
Series:	Journal of Translational Medicine
Assuntos:	Immune checkpoint Programmed cell death 1 Non-small cell lung cancer Cancer diagnostic Combinatorial library Protein engineering
Acceso en liña:	https://doi.org/10.1186/s12967-024-05210-x
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!